EPCO-56. RARE COMBINATION OF PEDIATRIC POSTERIOR FOSSA EPENDYMOMA GROUP A, CONSTITUTIONAL KMT2D ALA2497VAL VARIANT AND CONGENITAL SOLITARY KIDNEY

Abstract Ependymoma in children is rarely associated with pathogenic germline variants. We describe co-occurrence of posterior fossa group A ependymoma, constitutional KMT2D (MLL2) variant of unknown clinical significance (VUS), and congenital solitary kidney in a child. KMT2D encodes a histone methyltransferase. Its constitutional loss-of-function variants are associated with Kabuki syndrome Type 1. A healthy 3-year-old identical twin boy presented with headache, ataxia, dysphagia and dysarthria. Brain MRI revealed calcified right-sided posterior fossa mass. Spine MRI showed solitary right kidney. His identical twin also had solitary right kidney. Tumor was partially resected. Pathology showed posterior fossa group A ependymoma with loss of H3K27me3 trimethylation and EZHIP expression. OncoKids somatic panel showed VUSs in KMT2D (NM_003482.3: c.7490C>T, p.Ala2497Val) and CHD7 (NM_017780:c.2830C>T, p.Arg944Cys) at variant allele frequencies of 49%. Targeted Sanger sequencing of blood demonstrated that the KMT2D variant was of germline origin. Germline testing for the CHD7 variant was not performed, but also presumed germline. Patient did not have overt features suggestive of Kabuki or CHARGE syndromes. KMT2D is implicated in neural crest cell development and migration. Loss of function variants in KMT2D are associated with autosomal dominant Kabuki syndrome affecting multiple systems including renal and cerebellar anomalies. To date, KMT2D Ala2497Val has not been linked to Kabuki syndrome. Case reports have associated various cancers with Kabuki syndrome, including one report of a spinal ependymoma, suggesting a cancer predisposition. CHD7 is also required for renal and cerebellar development. Germline variants of CHD7 are associated with CHARGE syndrome. The KMT2D and CHD7 variants are not predicted to reach pathogenic classification on their own. However, variants in both genes may contribute to cancer and syndromic disorders with renal and cerebellar anomalies. We posit that the combination of both variants contributed to this patient’s ependymoma and congenital solitary kidney. Additional studies are required to confirm this.

Authors

Institutions

Publication Details

Journal
Neuro-Oncology
Published
2025-11-01
DOI
https://doi.org/10.1093/neuonc/noaf201.0055
Primary Topic
Genomics and Rare Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

EPCO-56. RARE COMBINATION OF PEDIATRIC POSTERIOR FOSSA EPENDYMOMA GROUP A, CONSTITUTIONAL KMT2D ALA2497VAL VARIANT AND CONGENITAL SOLITARY KIDNEY

Benita Tamrazi, Anat Erdreich‐Epstein, Jianling Ji, Joshua A. Greenwald et al.
Neuro-Oncology
Genomics and Rare Diseases
article

EPCO-56. RARE COMBINATION OF PEDIATRIC POSTERIOR FOSSA EPENDYMOMA GROUP A, CONSTITUTIONAL KMT2D ALA2497VAL VARIANT AND CONGENITAL SOLITARY KIDNEY

Benita Tamrazi, Anat Erdreich‐Epstein, Jianling Ji, Joshua A. Greenwald, Mark D. Krieger, Kenneth Wong, Matthew A. Deardorff, Tara K Tekkey
article en

Abstract

Abstract Ependymoma in children is rarely associated with pathogenic germline variants. We describe co-occurrence of posterior fossa group A ependymoma, constitutional KMT2D (MLL2) variant of unknown clinical significance (VUS), and congenital solitary kidney in a child. KMT2D encodes a histone methyltransferase. Its constitutional loss-of-function variants are associated with Kabuki syndrome Type 1. A healthy 3-year-old identical twin boy presented with headache, ataxia, dysphagia and dysarthria. Brain MRI revealed calcified right-sided posterior fossa mass. Spine MRI showed solitary right kidney. His identical twin also had solitary right kidney. Tumor was partially resected. Pathology showed posterior fossa group A ependymoma with loss of H3K27me3 trimethylation and EZHIP expression. OncoKids somatic panel showed VUSs in KMT2D (NM_003482.3: c.7490C>T, p.Ala2497Val) and CHD7 (NM_017780:c.2830C>T, p.Arg944Cys) at variant allele frequencies of 49%. Targeted Sanger sequencing of blood demonstrated that the KMT2D variant was of germline origin. Germline testing for the CHD7 variant was not performed, but also presumed germline. Patient did not have overt features suggestive of Kabuki or CHARGE syndromes. KMT2D is implicated in neural crest cell development and migration. Loss of function variants in KMT2D are associated with autosomal dominant Kabuki syndrome affecting multiple systems including renal and cerebellar anomalies. To date, KMT2D Ala2497Val has not been linked to Kabuki syndrome. Case reports have associated various cancers with Kabuki syndrome, including one report of a spinal ependymoma, suggesting a cancer predisposition. CHD7 is also required for renal and cerebellar development. Germline variants of CHD7 are associated with CHARGE syndrome. The KMT2D and CHD7 variants are not predicted to reach pathogenic classification on their own. However, variants in both genes may contribute to cancer and syndromic disorders with renal and cerebellar anomalies. We posit that the combination of both variants contributed to this patient’s ependymoma and congenital solitary kidney. Additional studies are required to confirm this.

Neuro-OncologyVol. 27(Supplement_5)
University of Southern California (US), Children's Hospital of Los Angeles (US), USC Norris Comprehensive Cancer Center (US), University of Toledo (US)
Openalex Percentile: Top 64%
Genomics and Rare Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.